Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Terumo Advanced Perfusion System 1

K-Number: K221895 · 2023-04-18

Decision Date2023-04-18
Product CodeDTQ
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

Terumo Advanced Perfusion System 1 is a medical device manufactured by Terumo Cardiovascular Systems Corporation. It received FDA 510(k) clearance on 2023-04-18 under approval number K221895. The device is classified under product code DTQ. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Terumo Advanced Perfusion System 1?

Terumo Advanced Perfusion System 1 is a medical device that received FDA 510(k) clearance on 2023-04-18. It is manufactured by Terumo Cardiovascular Systems Corporation. The 510(k) number is K221895.

When was Terumo Advanced Perfusion System 1 approved by the FDA?

Terumo Advanced Perfusion System 1 received FDA 510(k) clearance on 2023-04-18, under approval number K221895.

What company makes Terumo Advanced Perfusion System 1?

Terumo Advanced Perfusion System 1 is manufactured by Terumo Cardiovascular Systems Corporation.

What is the FDA product code for Terumo Advanced Perfusion System 1?

The FDA product code for Terumo Advanced Perfusion System 1 is DTQ.

Related Clinical Trials

Related PubMed Literature

Other Devices by Terumo Cardiovascular Systems Corporation

View all 10 devices →

Related Devices (Code: DTQ)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.